---
schema_version: "secwatch.filing_event.v1"
accession: "0001919246-26-000060"
form_type: "8-K"
ticker: "PTHS"
cik: "0001919246"
company_name: "Pelthos Therapeutics Inc."
filed_at: "2026-04-14T23:59:59+00:00"
generated_at: "2026-05-15T06:26:27.749226+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# CEO Scott Plesha to attend Piper Sandler Spring Biopharma Symposium on April 16, 2026

## Summary
- CEO will hold one-on-one investor meetings at conference in Boston.
- Corporate presentation made available on company website but contains no new material disclosures.
- No financial results, pipeline updates, or material events announced.

## SEC filing metadata
- accession: 0001919246-26-000060
- form_type: 8-K
- ticker: PTHS
- cik: 0001919246
- company_name: Pelthos Therapeutics Inc.
- filed_at: 2026-04-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1919246/000191924626000060/0001919246-26-000060-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1919246/000191924626000060/pths-20260414.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001919246-26-000060
- JSON: https://secwatch.observer/filing/0001919246-26-000060.json
- Plain text: https://secwatch.observer/filing/0001919246-26-000060.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.